Dystrophic Epidermolysis Bullosa Research Association (DEBRA): International Research Grants

Current research priorities: biology and genetics of all forms of EB, new approaches to diagnose and treat EB, development of therapies (including possible gene-therapies, cell-therapies, drug therapies or protein therapies), the nature of wound healing and the development of skin cancer in EB and seek to develop better treatments and prevention strategies, clinical care research to improve the management of EB through symptom relief. Funding: typically €80K/year for up to 3 years.

http://www.debra-international.org/research/funding.html#c2852